Ophthalmology Drugs & Devices Market Size - Forecasts to 2026

 

The findings reviewed by GME stated that the Global Ophthalmology Drugs & Devices Market will expand with a CAGR value of 5.9 percent from 2021 to 2026. Increasing incidences of eyesight disorders and the growing geriatric population associated with cataract disorder are expected to contribute to the growth of ophthalmology devices and drugs market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Ophthalmology Drugs & Devices Market - Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs-devices-market-2914

By Product (Diagnostic and Monitoring Devices [Optical Coherence Tomographers (OCT), Ophthalmic Ultrasound Imaging Systems, Fundus Cameras, Ophthalmoscopes, Retinoscopes, Wavefront Aberrometer, Corneal Topographer, Autorefractors/Phoropters, Pachymeters, Keratometers, Specular Microscopes, Biometers, Visual Field Analyzers/Perimeter, Tonometers, Slit Lamps, Optotype Projectors, Dioptometers], Surgical Devices [Cataract {Intraocular Lens (IOL), Ophthalmic Viscoelastic Devices (OVD), Phacoemulsification Devices}, Glaucoma {Glaucoma Drainage Devices (GDD), Stents and Implants, Glaucoma Lasers, Glaucoma Systems}, Refractive Error {Excimer Laser, YAG Laser, Microkeratome, Femtosecond Laser}, Vitreoretinal {Vitrectomy Machines, Photocoagulation Lasers, Illumination Devices}], Vision Care [Contact Lenses, Spectacles], Drugs [Existing Treatment Drugs, Drugs in Pipeline]), By Indication (Glaucoma, Retinal Disorders [Age-related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema] Dry Eye, Allergy/Inflammation/Conjunctivitis) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

 Key Market Insights

·       Ophthalmology drugs & devices are used to correct eyesight disorders and restore vision and hence this market will be growing rapidly during the forecast period

·       The increasing instances of eyesight disorders and the growing number of diabetes patients are expected to increase the demand for ophthalmology devices and drugs.

·       The largest shareholder of the ophthalmology drugs & devices market is the vision care segment in 2020 as per the product type outlook

·       Topcon (Japan), Allergan (U.S.), Alcon (U.S.), Merck (U.S.), Roche (Switzerland), Pfizer (U.S.), Santen (Japan), Bausch & Lomb, Inc. (U.S.), Abbott Medical Optics (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), ), Essilor (France), and Nidek (Japan), among others, are the major vendors competing in the ophthalmology drugs & devices market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs-devices-market-2914

Product Outlook (Revenue, USD Billion, 2021-2026)

·       Diagnostic and Monitoring Devices

·       Optical Coherence Tomographers (OCT)

·       Ophthalmic Ultrasound Imaging Systems

·       Fundus Cameras

·       Ophthalmoscopes

·       Retinoscopes

·       Wavefront Aberrometer

·       Corneal Topographer

·       Autorefractors/Phoropters

·       Pachymeters

·       Keratometers

·       Specular Microscopes

·       Biometers

·       Visual Field Analyzers/Perimeter

·       Tonometers

·       Slit Lamps

·       Optotype Projectors

·       Dioptometers

·       Vision Care

·       Contact Lenses

·       Spectacles

·       Surgical Devices

·       Cataracts

§  Intraocular Lens (IOL)

§  Ophthalmic Viscoelastic Devices (OVD)

§  Phacoemulsification Devices

·       Glaucoma

§  Glaucoma Drainage Devices (GDD)

§  Stents and Implants

§  Glaucoma Lasers

§  Glaucoma Systems

·       Refractive Error

§  Excimer Laser

§  YAG Laser

§  Microkeratome

§  Femtosecond Laser

·       Vitreoretinal

§  Vitrectomy Machines

§  Photocoagulation Lasers

§  Illumination Devices

Indication Outlook (Revenue, USD Billion, 2021-2026)

·       Glaucoma

·       Retinal Disorders (Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema)

·       Dry Eye

·       Allergy/Inflammation/Conjunctivitis

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php